ResMed Long Term Debt 2010-2024 | RMD
ResMed long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
- ResMed long term debt for the quarter ending March 31, 2024 was $0.997B, a 36.73% decline year-over-year.
- ResMed long term debt for 2023 was $1.431B, a 87.01% increase from 2022.
- ResMed long term debt for 2022 was $0.765B, a 18.96% increase from 2021.
- ResMed long term debt for 2021 was $0.643B, a 44.74% decline from 2020.
| ResMed Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2023 | $1,431 |
| 2022 | $765 |
| 2021 | $643 |
| 2020 | $1,164 |
| 2019 | $1,259 |
| 2018 | $270 |
| 2017 | $1,079 |
| 2016 | $873 |
| 2015 | $301 |
| 2014 | $301 |
| 2013 | $1 |
| 2012 | $251 |
| 2011 | $100 |
| 2010 | $ |
| 2009 | $94 |
| ResMed Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2024-03-31 | $997 |
| 2023-12-31 | $1,217 |
| 2023-09-30 | $1,352 |
| 2023-06-30 | $1,431 |
| 2023-03-31 | $1,576 |
| 2022-12-31 | $1,791 |
| 2022-09-30 | $785 |
| 2022-06-30 | $765 |
| 2022-03-31 | $669 |
| 2021-12-31 | $668 |
| 2021-09-30 | $794 |
| 2021-06-30 | $643 |
| 2021-03-31 | $719 |
| 2020-12-31 | $814 |
| 2020-09-30 | $1,044 |
| 2020-06-30 | $1,164 |
| 2020-03-31 | $1,365 |
| 2019-12-31 | $1,288 |
| 2019-09-30 | $1,208 |
| 2019-06-30 | $1,259 |
| 2019-03-31 | $1,323 |
| 2018-12-31 | $1,186 |
| 2018-09-30 | $518 |
| 2018-06-30 | $270 |
| 2018-03-31 | $810 |
| 2017-12-31 | |
| 2017-09-30 | $1,019 |
| 2017-06-30 | $1,079 |
| 2017-03-31 | $1,168 |
| 2016-12-31 | $869 |
| 2016-09-30 | $874 |
| 2016-06-30 | $873 |
| 2016-03-31 | $436 |
| 2015-12-31 | $401 |
| 2015-09-30 | $501 |
| 2015-06-30 | $301 |
| 2015-03-31 | $461 |
| 2014-12-31 | $450 |
| 2014-09-30 | $376 |
| 2014-06-30 | $301 |
| 2014-03-31 | $396 |
| 2013-12-31 | $436 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $301 |
| 2012-09-30 | $266 |
| 2012-06-30 | $251 |
| 2012-03-31 | $235 |
| 2011-12-31 | $225 |
| 2011-09-30 | $130 |
| 2011-06-30 | $100 |
| 2011-03-31 | $80 |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | $29 |
| 2009-12-31 | $95 |
| 2009-09-30 | $95 |
| 2009-06-30 | $94 |
| 2009-03-31 | $93 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $27.824B | $4.223B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.017B | 23.31 |
| Stryker (SYK) | United States | $126.483B | 30.29 |
| Boston Scientific (BSX) | United States | $111.661B | 35.56 |
| EssilorLuxottica (ESLOY) | France | $99.732B | 0.00 |
| Medtronic (MDT) | Ireland | $98.953B | 14.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.630B | 28.20 |
| Terumo (TRUMY) | Japan | $24.790B | 35.01 |
| Koninklijke Philips (PHG) | Netherlands | $23.594B | 18.73 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.927B | 14.01 |
| Baxter (BAX) | United States | $16.898B | 12.01 |
| Insulet (PODD) | United States | $13.778B | 61.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.986B | 0.00 |
| Demant (WILYY) | Denmark | $9.175B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.709B | 36.26 |
| Bio-Rad Laboratories (BIO) | United States | $7.704B | 25.19 |
| Lantheus Holdings (LNTH) | United States | $5.515B | 13.74 |
| Haemonetics (HAE) | United States | $4.287B | 21.14 |
| GN Store Nord (GNNDY) | Denmark | $4.205B | 23.62 |
| Perrigo (PRGO) | Ireland | $3.570B | 10.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.360B | 15.99 |
| Neogen (NEOG) | United States | $3.295B | 31.69 |
| TG Therapeutics (TGTX) | United States | $2.904B | 81.70 |
| ICU Medical (ICUI) | United States | $2.875B | 25.37 |
| Envista Holdings (NVST) | United States | $2.800B | 11.55 |
| Green Thumb Industries (GTBIF) | United States | $2.467B | 48.29 |
| Agios Pharmaceuticals (AGIO) | United States | $2.386B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.077B | 11.53 |
| LeMaitre Vascular (LMAT) | United States | $1.825B | 53.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.761B | 0.00 |
| Warby Parker (WRBY) | United States | $1.609B | 0.00 |
| InMode (INMD) | Israel | $1.468B | 7.80 |
| Verano Holdings (VRNOF) | United States | $1.292B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.292B | 9.60 |
| AtriCure (ATRC) | United States | $1.068B | 0.00 |
| Owens & Minor (OMI) | United States | $1.003B | 8.74 |
| National Vision Holdings (EYE) | United States | $0.977B | 31.08 |
| BioLife Solutions (BLFS) | United States | $0.923B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.791B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.694B | 14.78 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| PetIQ (PETQ) | United States | $0.672B | 21.73 |
| Surmodics (SRDX) | United States | $0.599B | 37.48 |
| VAREX IMAGING (VREX) | United States | $0.587B | 13.81 |
| ZimVie (ZIMV) | United States | $0.506B | 43.16 |
| Valneva SE (VALN) | France | $0.501B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.495B | 0.00 |
| Quanterix (QTRX) | United States | $0.479B | 0.00 |
| Biote (BTMD) | United States | $0.459B | 10.57 |
| Jin Medical (ZJYL) | China | $0.438B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
| Cerus (CERS) | United States | $0.318B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.298B | 9.60 |
| Zynex (ZYXI) | United States | $0.283B | 38.78 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 0.00 |
| MacroGenics (MGNX) | United States | $0.263B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.256B | 25.39 |
| Sanara MedTech (SMTI) | United States | $0.238B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.234B | 14.75 |
| Omeros (OMER) | United States | $0.225B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.220B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.165B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 19.89 |
| Veru (VERU) | United States | $0.134B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 10.29 |
| Brainsway (BWAY) | Israel | $0.099B | 0.00 |
| InterCure (INCR) | Israel | $0.097B | 16.31 |
| Cellectar Biosciences (CLRB) | United States | $0.089B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.071B | 4.66 |
| MariMed (MRMD) | United States | $0.071B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Bright Green (BGXX) | United States | $0.050B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.044B | 15.97 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| Agape ATP (ATPC) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |